Stryker vs. Johnson & Johnson vs. Zimmer Biomet: How they compare in Q2

Stryker, Johnson & Johnson and Zimmer Biomet all saw year-over-year total revenue increases during the second quarter, but their spine and orthopedic sales varied in growth.

Advertisement

Here is how their second-quarter performances compare:

Stryker

Total sales: $4.5 billion (+4.6 percent)

Orthopedics and spine: $1.9 billion (0.5 percent)

Hips: $364 million (+3.2 percent)

Knees: $500 million (+5.5 percent)

Johnson & Johnson

Total sales: $24 billion (+3 percent)

Spine, sports and other: $724 million (-6.8 percent)

Orthopedic: $2.2 billion (-3.1 percent)

Hips: $388 million (-0.7 percent)

Knees: $349 million (-0.1 percent)

Zimmer Biomet

Total sales: $1.8 billion (+1 percent)

Hips: $487.2 million (+2.7 percent)

Knees: $704.9 million (+5.9 percent)

Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $446.4 million (-3.4 percent)

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.